BONANNI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 12.786
EU - Europa 10.227
AS - Asia 8.952
SA - Sud America 1.471
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 22
Totale 33.635
Nazione #
US - Stati Uniti d'America 12.508
SG - Singapore 3.625
CN - Cina 2.369
IT - Italia 2.255
RU - Federazione Russa 1.734
IE - Irlanda 1.345
BR - Brasile 1.167
UA - Ucraina 1.150
VN - Vietnam 932
GB - Regno Unito 852
TR - Turchia 819
SE - Svezia 786
DE - Germania 685
FR - Francia 575
IN - India 446
FI - Finlandia 332
HK - Hong Kong 204
CA - Canada 156
AR - Argentina 106
JP - Giappone 96
MX - Messico 90
NL - Olanda 87
BD - Bangladesh 86
PL - Polonia 85
AT - Austria 67
IQ - Iraq 67
ES - Italia 64
ZA - Sudafrica 64
EC - Ecuador 49
CZ - Repubblica Ceca 47
ID - Indonesia 39
CO - Colombia 35
PK - Pakistan 33
IR - Iran 30
BE - Belgio 29
VE - Venezuela 29
CL - Cile 28
KR - Corea 26
LU - Lussemburgo 25
PE - Perù 21
UZ - Uzbekistan 21
MA - Marocco 20
EU - Europa 19
LT - Lituania 19
JO - Giordania 18
PY - Paraguay 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
IL - Israele 16
EG - Egitto 15
RO - Romania 15
AU - Australia 14
CH - Svizzera 13
TN - Tunisia 13
AZ - Azerbaigian 11
DK - Danimarca 11
DZ - Algeria 10
OM - Oman 10
PT - Portogallo 10
DO - Repubblica Dominicana 8
LB - Libano 8
MY - Malesia 8
PH - Filippine 8
UY - Uruguay 8
KE - Kenya 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
BO - Bolivia 6
JM - Giamaica 6
SN - Senegal 6
ET - Etiopia 5
GR - Grecia 5
HN - Honduras 5
KZ - Kazakistan 5
AM - Armenia 4
BG - Bulgaria 4
GY - Guiana 4
HU - Ungheria 4
KH - Cambogia 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
AL - Albania 3
KG - Kirghizistan 3
LV - Lettonia 3
SC - Seychelles 3
SM - San Marino 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
QA - Qatar 2
RS - Serbia 2
Totale 33.608
Città #
Singapore 2.665
Chandler 1.491
Jacksonville 1.342
San Jose 1.328
Dublin 1.322
Ashburn 967
Princeton 621
Dallas 603
Southend 570
Beijing 566
Izmir 419
Nanjing 408
Los Angeles 331
Ho Chi Minh City 304
Dearborn 290
Santa Clara 285
Wilmington 273
The Dalles 242
New York 222
Cambridge 210
Chieti 202
Hanoi 200
Altamura 195
Munich 191
Hong Kong 183
Tongling 159
Ann Arbor 144
Nanchang 139
Buffalo 124
São Paulo 123
Rome 121
Boardman 115
Moscow 114
Pescara 112
Redondo Beach 112
Council Bluffs 99
Milan 98
Orem 83
Helsinki 76
Woodbridge 76
Tokyo 72
Hebei 69
Tianjin 69
Washington 67
Warsaw 66
Shenyang 61
Kunming 57
Brooklyn 55
Chennai 55
London 55
Toronto 55
Houston 54
Turku 54
Frankfurt am Main 53
Denver 51
Montreal 51
Nuremberg 51
Grevenbroich 49
Hefei 49
Chicago 46
Jiaxing 44
Norwalk 44
Belo Horizonte 42
Changsha 41
Da Nang 41
Seattle 41
Atlanta 40
Johannesburg 40
Stockholm 40
Haiphong 39
Poplar 38
Hangzhou 35
Jinan 35
Dong Ket 34
Mexico City 33
Amsterdam 32
Manchester 32
Florence 31
Brno 30
Biên Hòa 28
Phoenix 28
Vienna 28
Rio de Janeiro 27
Augusta 26
Capurso 26
San Francisco 26
Falls Church 24
Pune 24
Baghdad 23
Boston 23
Brussels 23
Lanzhou 23
Mumbai 23
New Delhi 23
Paris 23
Hải Dương 22
Leawood 22
Naples 22
Ardabil 21
Seoul 21
Totale 19.482
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.088
Emergenza neurologica - tempesta distonica: diagnosi e terapia 483
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 313
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 278
Pre-trattamento antiematico per Test/terapia all'apomorfina 197
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 183
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 182
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 178
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 176
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 176
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 171
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 171
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 164
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 163
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 163
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 163
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 162
Akinetic crisis in Dementia with Lewy Bodies 162
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 158
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 156
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 155
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 154
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 153
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 152
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 152
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 149
Progetto atrofia multisistemica: risultati preliminari. 149
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 148
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 147
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 147
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 147
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 147
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 146
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 146
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 145
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 144
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 144
Bipallidal lesions induce delayed and progressive parkinsonism 143
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 142
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 140
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 139
Autoscopic phenomena: case report and review of literature. 138
Attention network in AD and DLB patients: a resting fMRI study. 138
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 138
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 137
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 137
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 137
Improving diagnostic accuracy of DLB: An MRI study 136
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 134
Instabilità posturale nel Parkinson non farmaco-responder 133
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 132
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 132
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 132
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 132
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 131
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 129
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 129
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 128
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 126
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 125
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 125
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 125
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 124
A stage-based approach to therapy in parkinson’s disease 124
Pathological Gambling in PD is reduced by Amantadine 123
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 123
Atrofia Multisistemica: approccio diagnostico multidisciplinare 123
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 123
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 123
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 123
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 123
Mitochondrial Involvement in Neurodegenerative Dementia 123
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel 123
Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease 122
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 122
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 121
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase 121
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 121
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 121
"Occipital Pole" Sign on 18F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy: Evidence From the Treviso Dementia (TREDEM) Registry 121
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 120
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 120
Serial analysis of peripheral blood T cell receptor (TCR) V beta repertoire by RT-PCR/SSCP in patients with multiple sclerosis (MS) and healthy controls. 120
Catamenial end-off dose in Parkinson's disease 120
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 120
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 120
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 119
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 119
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 119
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 119
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium 119
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 118
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 118
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 118
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 117
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 116
The pharmacology of visual hallucinations in synucleinopathies 116
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 116
Interictal Heart Rate Variability Analysis Reveals Lateralization of Cardiac Autonomic Control in Temporal Lobe Epilepsy 116
Totale 15.339
Categoria #
all - tutte 133.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 0 0 0 0 0 207 154 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20255.465 303 919 827 146 155 236 254 286 468 348 612 911
2025/202611.696 959 442 1.252 1.654 1.123 760 1.951 724 1.943 888 0 0
Totale 34.587